These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27420626)

  • 21. Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase.
    Sokolov AV; Pulina MO; Ageeva KV; Ayrapetov MI; Berlov MN; Volgin GN; Markov AG; Yablonsky PK; Kolodkin NI; Zakharova ET; Vasilyev VB
    Biochemistry (Mosc); 2007 Apr; 72(4):409-15. PubMed ID: 17511605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
    Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC
    J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of serum neutrophil markers and acute coronary syndrome.
    Alfakry H; Sinisalo J; Paju S; Nieminen MS; Valtonen V; Tervahartiala T; Pussinen PJ; Sorsa T
    Scand J Immunol; 2012 Aug; 76(2):181-7. PubMed ID: 22537345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active and total myeloperoxidase in coronary artery disease and relation to clinical instability.
    Gach O; Brogneaux C; Franck T; Serteyn D; Legrand V; Pierard LA; Magne J
    Acta Cardiol; 2015 Oct; 70(5):522-7. PubMed ID: 26567811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
    O'Conor K; Chang AM; Wu AH; Hollander JE
    Am J Emerg Med; 2013 Apr; 31(4):664-9. PubMed ID: 23380098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study.
    Quidim AV; Bruno TC; Lacerda Leocádio PC; Dos Reis Menta PL; Alvarez-Leite JI; Santos IS; Lotufo PA; Benseñor IM; Goulart AC
    Biomark Med; 2018 Nov; 12(11):1219-1229. PubMed ID: 30456985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
    Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD
    Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OX40 ligand levels and high-sensitivity C-reactive protein levels in blood from local coronary plaque and the femoral artery in patients with acute coronary syndrome or stable angina.
    Shi JZ; Wang LY; Zhu Y; Zhao CY; Liu W; Jiang SL; You HW; Wang Y; Xu FY; Tang YS; Cui LQ
    J Int Med Res; 2011; 39(4):1275-83. PubMed ID: 21986129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina.
    Naruko T; Furukawa A; Yunoki K; Komatsu R; Nakagawa M; Matsumura Y; Shirai N; Sugioka K; Takagi M; Hozumi T; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Heart; 2010 Nov; 96(21):1716-22. PubMed ID: 20956487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
    Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D
    Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients.
    Baskin E; Bakkaloglu A; Besbas N; Hascelik G; Saatci U; Gök F; Ozen S
    Pediatr Nephrol; 2002 Nov; 17(11):917-9. PubMed ID: 12432434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloperoxidase-Related Chlorination Activity Is Positively Associated with Circulating Ceruloplasmin in Chronic Heart Failure Patients: Relationship with Neurohormonal, Inflammatory, and Nutritional Parameters.
    Cabassi A; Binno SM; Tedeschi S; Graiani G; Galizia C; Bianconcini M; Coghi P; Fellini F; Ruffini L; Govoni P; Piepoli M; Perlini S; Regolisti G; Fiaccadori E
    Biomed Res Int; 2015; 2015():691693. PubMed ID: 26539521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High potential to reverse the inhibition of myeloperoxidase by ceruloplasmin of anti-myeloperoxidase autoantibodies of IgG3 subclass.
    Xu PC; Chen M; Zhao MH
    Autoimmunity; 2012 May; 45(3):218-25. PubMed ID: 21875381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.
    Zhou T; Zhou SH; Qi SS; Shen XQ; Zeng GF; Zhou HN
    Clin Chim Acta; 2006 Jun; 368(1-2):168-72. PubMed ID: 16480969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
    Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
    Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia.
    Olsson I; Olofsson T; Ohlsson K; Gustavsson A
    Scand J Haematol; 1979 May; 22(5):397-406. PubMed ID: 224448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome.
    Dullaart RP; Tietge UJ; Kwakernaak AJ; Dikkeschei BD; Perton F; Tio RA
    Atherosclerosis; 2014 May; 234(1):185-92. PubMed ID: 24661908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
    Marshall CJ; Nallaratnam M; Mocatta T; Smyth D; Richards M; Elliott JM; Blake J; Winterbourn CC; Kettle AJ; McClean DR
    Am J Cardiol; 2010 Aug; 106(3):316-22. PubMed ID: 20643239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.